nodes	percent_of_prediction	percent_of_DWPC	metapath
Orphenadrine—Mepyramine—Rosiglitazone—type 2 diabetes mellitus	0.235	0.67	CrCrCtD
Orphenadrine—CYP2E1—type 2 diabetes mellitus	0.183	0.614	CbGaD
Orphenadrine—Tripelennamine—Rosiglitazone—type 2 diabetes mellitus	0.116	0.33	CrCrCtD
Orphenadrine—CYP3A4—type 2 diabetes mellitus	0.115	0.386	CbGaD
Orphenadrine—CYP3A4—Linagliptin—type 2 diabetes mellitus	0.0182	0.152	CbGbCtD
Orphenadrine—CYP3A4—Sitagliptin—type 2 diabetes mellitus	0.0163	0.136	CbGbCtD
Orphenadrine—CYP3A4—Glipizide—type 2 diabetes mellitus	0.0149	0.124	CbGbCtD
Orphenadrine—CYP3A4—Repaglinide—type 2 diabetes mellitus	0.013	0.109	CbGbCtD
Orphenadrine—CYP3A4—Pioglitazone—type 2 diabetes mellitus	0.0117	0.0982	CbGbCtD
Orphenadrine—CYP3A4—Nateglinide—type 2 diabetes mellitus	0.0089	0.0744	CbGbCtD
Orphenadrine—CYP3A4—Irbesartan—type 2 diabetes mellitus	0.00854	0.0714	CbGbCtD
Orphenadrine—CYP3A4—Orlistat—type 2 diabetes mellitus	0.00854	0.0714	CbGbCtD
Orphenadrine—CYP3A4—Bromocriptine—type 2 diabetes mellitus	0.00807	0.0675	CbGbCtD
Orphenadrine—CYP3A4—Glyburide—type 2 diabetes mellitus	0.00601	0.0503	CbGbCtD
Orphenadrine—CYP3A4—Losartan—type 2 diabetes mellitus	0.0055	0.046	CbGbCtD
Orphenadrine—SLC6A2—sympathetic nervous system—type 2 diabetes mellitus	0.00232	0.158	CbGeAlD
Orphenadrine—SCN10A—peripheral nervous system—type 2 diabetes mellitus	0.00181	0.123	CbGeAlD
Orphenadrine—SLC6A2—autonomic nervous system—type 2 diabetes mellitus	0.00156	0.106	CbGeAlD
Orphenadrine—SCN10A—nerve—type 2 diabetes mellitus	0.00141	0.096	CbGeAlD
Orphenadrine—SLC6A2—nerve—type 2 diabetes mellitus	0.000876	0.0597	CbGeAlD
Orphenadrine—SCN9A—nephron tubule—type 2 diabetes mellitus	0.000721	0.0492	CbGeAlD
Orphenadrine—Palpitations—Repaglinide—type 2 diabetes mellitus	0.000673	0.00563	CcSEcCtD
Orphenadrine—Constipation—Linagliptin—type 2 diabetes mellitus	0.000656	0.00549	CcSEcCtD
Orphenadrine—Feeling abnormal—Tolazamide—type 2 diabetes mellitus	0.000638	0.00535	CcSEcCtD
Orphenadrine—Constipation—Acarbose—type 2 diabetes mellitus	0.000636	0.00533	CcSEcCtD
Orphenadrine—Anaphylactic shock—Repaglinide—type 2 diabetes mellitus	0.000621	0.0052	CcSEcCtD
Orphenadrine—Tension—Glipizide—type 2 diabetes mellitus	0.000618	0.00517	CcSEcCtD
Orphenadrine—Urticaria—Chlorpropamide—type 2 diabetes mellitus	0.000615	0.00515	CcSEcCtD
Orphenadrine—Urticaria—Tolazamide—type 2 diabetes mellitus	0.000615	0.00515	CcSEcCtD
Orphenadrine—Urticaria—Linagliptin—type 2 diabetes mellitus	0.000609	0.0051	CcSEcCtD
Orphenadrine—Hallucination—Bromocriptine—type 2 diabetes mellitus	0.000606	0.00507	CcSEcCtD
Orphenadrine—Skin disorder—Repaglinide—type 2 diabetes mellitus	0.000603	0.00505	CcSEcCtD
Orphenadrine—Pruritus—Tolbutamide—type 2 diabetes mellitus	0.000602	0.00504	CcSEcCtD
Orphenadrine—Vision blurred—Glipizide—type 2 diabetes mellitus	0.000593	0.00497	CcSEcCtD
Orphenadrine—Urticaria—Acarbose—type 2 diabetes mellitus	0.000591	0.00495	CcSEcCtD
Orphenadrine—Tremor—Glipizide—type 2 diabetes mellitus	0.00059	0.00494	CcSEcCtD
Orphenadrine—Anaphylactic shock—Rosiglitazone—type 2 diabetes mellitus	0.000587	0.00492	CcSEcCtD
Orphenadrine—Tension—Glimepiride—type 2 diabetes mellitus	0.000577	0.00483	CcSEcCtD
Orphenadrine—Tension—Sitagliptin—type 2 diabetes mellitus	0.000575	0.00481	CcSEcCtD
Orphenadrine—SCN9A—adipose tissue—type 2 diabetes mellitus	0.000571	0.039	CbGeAlD
Orphenadrine—Urticaria—Nateglinide—type 2 diabetes mellitus	0.00057	0.00477	CcSEcCtD
Orphenadrine—SCN4A—kidney—type 2 diabetes mellitus	0.000566	0.0386	CbGeAlD
Orphenadrine—Hypersensitivity—Linagliptin—type 2 diabetes mellitus	0.000565	0.00473	CcSEcCtD
Orphenadrine—Nausea—Miglitol—type 2 diabetes mellitus	0.000562	0.00471	CcSEcCtD
Orphenadrine—Drowsiness—Gliclazide—type 2 diabetes mellitus	0.000557	0.00466	CcSEcCtD
Orphenadrine—Asthenia—Tolazamide—type 2 diabetes mellitus	0.000556	0.00465	CcSEcCtD
Orphenadrine—Vision blurred—Glimepiride—type 2 diabetes mellitus	0.000554	0.00464	CcSEcCtD
Orphenadrine—Vision blurred—Sitagliptin—type 2 diabetes mellitus	0.000552	0.00462	CcSEcCtD
Orphenadrine—Tremor—Glimepiride—type 2 diabetes mellitus	0.00055	0.00461	CcSEcCtD
Orphenadrine—SCN10A—nephron tubule—type 2 diabetes mellitus	0.000549	0.0374	CbGeAlD
Orphenadrine—Hypersensitivity—Acarbose—type 2 diabetes mellitus	0.000548	0.00459	CcSEcCtD
Orphenadrine—Pruritus—Chlorpropamide—type 2 diabetes mellitus	0.000548	0.00459	CcSEcCtD
Orphenadrine—Pruritus—Tolazamide—type 2 diabetes mellitus	0.000548	0.00459	CcSEcCtD
Orphenadrine—Agitation—Glimepiride—type 2 diabetes mellitus	0.00054	0.00452	CcSEcCtD
Orphenadrine—Headache—Tolbutamide—type 2 diabetes mellitus	0.000533	0.00447	CcSEcCtD
Orphenadrine—Constipation—Repaglinide—type 2 diabetes mellitus	0.000531	0.00445	CcSEcCtD
Orphenadrine—Hypersensitivity—Nateglinide—type 2 diabetes mellitus	0.000529	0.00443	CcSEcCtD
Orphenadrine—Tension—Bromocriptine—type 2 diabetes mellitus	0.00052	0.00436	CcSEcCtD
Orphenadrine—Palpitations—Glimepiride—type 2 diabetes mellitus	0.000519	0.00435	CcSEcCtD
Orphenadrine—Confusional state—Glipizide—type 2 diabetes mellitus	0.000518	0.00434	CcSEcCtD
Orphenadrine—Asthenia—Nateglinide—type 2 diabetes mellitus	0.000515	0.00431	CcSEcCtD
Orphenadrine—Dizziness—Chlorpropamide—type 2 diabetes mellitus	0.000512	0.00429	CcSEcCtD
Orphenadrine—Dizziness—Tolazamide—type 2 diabetes mellitus	0.000512	0.00429	CcSEcCtD
Orphenadrine—SCN4A—adipose tissue—type 2 diabetes mellitus	0.00051	0.0347	CbGeAlD
Orphenadrine—Pruritus—Nateglinide—type 2 diabetes mellitus	0.000508	0.00425	CcSEcCtD
Orphenadrine—Nausea—Tolbutamide—type 2 diabetes mellitus	0.000506	0.00424	CcSEcCtD
Orphenadrine—Constipation—Rosiglitazone—type 2 diabetes mellitus	0.000502	0.0042	CcSEcCtD
Orphenadrine—Vision blurred—Bromocriptine—type 2 diabetes mellitus	0.0005	0.00418	CcSEcCtD
Orphenadrine—Urticaria—Repaglinide—type 2 diabetes mellitus	0.000493	0.00413	CcSEcCtD
Orphenadrine—Vomiting—Chlorpropamide—type 2 diabetes mellitus	0.000492	0.00412	CcSEcCtD
Orphenadrine—Anaphylactic shock—Pioglitazone—type 2 diabetes mellitus	0.000492	0.00412	CcSEcCtD
Orphenadrine—Agitation—Bromocriptine—type 2 diabetes mellitus	0.000487	0.00408	CcSEcCtD
Orphenadrine—Headache—Tolazamide—type 2 diabetes mellitus	0.000485	0.00406	CcSEcCtD
Orphenadrine—Headache—Chlorpropamide—type 2 diabetes mellitus	0.000485	0.00406	CcSEcCtD
Orphenadrine—Confusional state—Glimepiride—type 2 diabetes mellitus	0.000484	0.00405	CcSEcCtD
Orphenadrine—Headache—Linagliptin—type 2 diabetes mellitus	0.00048	0.00402	CcSEcCtD
Orphenadrine—Anaphylactic shock—Glimepiride—type 2 diabetes mellitus	0.00048	0.00402	CcSEcCtD
Orphenadrine—Skin disorder—Pioglitazone—type 2 diabetes mellitus	0.000478	0.004	CcSEcCtD
Orphenadrine—Anaphylactic shock—Sitagliptin—type 2 diabetes mellitus	0.000478	0.004	CcSEcCtD
Orphenadrine—Dizziness—Nateglinide—type 2 diabetes mellitus	0.000475	0.00397	CcSEcCtD
Orphenadrine—Vomiting—Acarbose—type 2 diabetes mellitus	0.000473	0.00396	CcSEcCtD
Orphenadrine—Tachycardia—Glimepiride—type 2 diabetes mellitus	0.000468	0.00392	CcSEcCtD
Orphenadrine—Urticaria—Rosiglitazone—type 2 diabetes mellitus	0.000466	0.00391	CcSEcCtD
Orphenadrine—Drowsiness—Metformin—type 2 diabetes mellitus	0.000466	0.0039	CcSEcCtD
Orphenadrine—Skin disorder—Sitagliptin—type 2 diabetes mellitus	0.000464	0.00389	CcSEcCtD
Orphenadrine—Nausea—Tolazamide—type 2 diabetes mellitus	0.00046	0.00385	CcSEcCtD
Orphenadrine—Nausea—Chlorpropamide—type 2 diabetes mellitus	0.00046	0.00385	CcSEcCtD
Orphenadrine—Hypersensitivity—Repaglinide—type 2 diabetes mellitus	0.000458	0.00383	CcSEcCtD
Orphenadrine—Somnolence—Glipizide—type 2 diabetes mellitus	0.000457	0.00383	CcSEcCtD
Orphenadrine—Vision blurred—Glyburide—type 2 diabetes mellitus	0.000457	0.00382	CcSEcCtD
Orphenadrine—Vomiting—Nateglinide—type 2 diabetes mellitus	0.000456	0.00382	CcSEcCtD
Orphenadrine—Tremor—Glyburide—type 2 diabetes mellitus	0.000454	0.0038	CcSEcCtD
Orphenadrine—SCN5A—cardiovascular system—type 2 diabetes mellitus	0.000448	0.0306	CbGeAlD
Orphenadrine—Nausea—Acarbose—type 2 diabetes mellitus	0.000442	0.0037	CcSEcCtD
Orphenadrine—Constipation—Glipizide—type 2 diabetes mellitus	0.000439	0.00368	CcSEcCtD
Orphenadrine—Pruritus—Repaglinide—type 2 diabetes mellitus	0.000439	0.00368	CcSEcCtD
Orphenadrine—Confusional state—Bromocriptine—type 2 diabetes mellitus	0.000436	0.00365	CcSEcCtD
Orphenadrine—Tension—Gliclazide—type 2 diabetes mellitus	0.000427	0.00358	CcSEcCtD
Orphenadrine—Somnolence—Glimepiride—type 2 diabetes mellitus	0.000426	0.00357	CcSEcCtD
Orphenadrine—Nausea—Nateglinide—type 2 diabetes mellitus	0.000426	0.00357	CcSEcCtD
Orphenadrine—Somnolence—Sitagliptin—type 2 diabetes mellitus	0.000425	0.00356	CcSEcCtD
Orphenadrine—Feeling abnormal—Glipizide—type 2 diabetes mellitus	0.000423	0.00355	CcSEcCtD
Orphenadrine—Tachycardia—Bromocriptine—type 2 diabetes mellitus	0.000422	0.00354	CcSEcCtD
Orphenadrine—Asthenia—Rosiglitazone—type 2 diabetes mellitus	0.000421	0.00353	CcSEcCtD
Orphenadrine—Skin disorder—Bromocriptine—type 2 diabetes mellitus	0.00042	0.00352	CcSEcCtD
Orphenadrine—Pruritus—Rosiglitazone—type 2 diabetes mellitus	0.000415	0.00348	CcSEcCtD
Orphenadrine—Constipation—Sitagliptin—type 2 diabetes mellitus	0.000409	0.00342	CcSEcCtD
Orphenadrine—Urticaria—Glipizide—type 2 diabetes mellitus	0.000408	0.00342	CcSEcCtD
Orphenadrine—Tremor—Gliclazide—type 2 diabetes mellitus	0.000408	0.00341	CcSEcCtD
Orphenadrine—Feeling abnormal—Pioglitazone—type 2 diabetes mellitus	0.000406	0.0034	CcSEcCtD
Orphenadrine—Agitation—Gliclazide—type 2 diabetes mellitus	0.0004	0.00335	CcSEcCtD
Orphenadrine—Confusional state—Glyburide—type 2 diabetes mellitus	0.000399	0.00334	CcSEcCtD
Orphenadrine—Feeling abnormal—Glimepiride—type 2 diabetes mellitus	0.000395	0.00331	CcSEcCtD
Orphenadrine—Vomiting—Repaglinide—type 2 diabetes mellitus	0.000395	0.00331	CcSEcCtD
Orphenadrine—Feeling abnormal—Sitagliptin—type 2 diabetes mellitus	0.000394	0.0033	CcSEcCtD
Orphenadrine—Urticaria—Pioglitazone—type 2 diabetes mellitus	0.000391	0.00328	CcSEcCtD
Orphenadrine—Headache—Repaglinide—type 2 diabetes mellitus	0.000389	0.00326	CcSEcCtD
Orphenadrine—Dizziness—Rosiglitazone—type 2 diabetes mellitus	0.000388	0.00325	CcSEcCtD
Orphenadrine—Somnolence—Bromocriptine—type 2 diabetes mellitus	0.000385	0.00322	CcSEcCtD
Orphenadrine—Palpitations—Gliclazide—type 2 diabetes mellitus	0.000385	0.00322	CcSEcCtD
Orphenadrine—CHRM2—cardiovascular system—type 2 diabetes mellitus	0.000382	0.026	CbGeAlD
Orphenadrine—KCNH2—islet of Langerhans—type 2 diabetes mellitus	0.000381	0.026	CbGeAlD
Orphenadrine—Urticaria—Glimepiride—type 2 diabetes mellitus	0.000381	0.00319	CcSEcCtD
Orphenadrine—Urticaria—Sitagliptin—type 2 diabetes mellitus	0.00038	0.00318	CcSEcCtD
Orphenadrine—Hypersensitivity—Glipizide—type 2 diabetes mellitus	0.000379	0.00317	CcSEcCtD
Orphenadrine—Vision blurred—Valsartan—type 2 diabetes mellitus	0.000377	0.00316	CcSEcCtD
Orphenadrine—Vision blurred—Orlistat—type 2 diabetes mellitus	0.000372	0.00312	CcSEcCtD
Orphenadrine—Constipation—Bromocriptine—type 2 diabetes mellitus	0.00037	0.0031	CcSEcCtD
Orphenadrine—Nausea—Repaglinide—type 2 diabetes mellitus	0.000369	0.00309	CcSEcCtD
Orphenadrine—Asthenia—Glipizide—type 2 diabetes mellitus	0.000369	0.00309	CcSEcCtD
Orphenadrine—Headache—Rosiglitazone—type 2 diabetes mellitus	0.000368	0.00308	CcSEcCtD
Orphenadrine—Pruritus—Glipizide—type 2 diabetes mellitus	0.000364	0.00304	CcSEcCtD
Orphenadrine—Hypersensitivity—Pioglitazone—type 2 diabetes mellitus	0.000363	0.00304	CcSEcCtD
Orphenadrine—Confusional state—Gliclazide—type 2 diabetes mellitus	0.000358	0.003	CcSEcCtD
Orphenadrine—Feeling abnormal—Bromocriptine—type 2 diabetes mellitus	0.000356	0.00299	CcSEcCtD
Orphenadrine—Aprindine—CALM1—type 2 diabetes mellitus	0.000356	0.0788	CrCbGaD
Orphenadrine—Hypersensitivity—Glimepiride—type 2 diabetes mellitus	0.000353	0.00296	CcSEcCtD
Orphenadrine—Palpitations—Valsartan—type 2 diabetes mellitus	0.000353	0.00296	CcSEcCtD
Orphenadrine—Asthenia—Pioglitazone—type 2 diabetes mellitus	0.000353	0.00296	CcSEcCtD
Orphenadrine—Hypersensitivity—Sitagliptin—type 2 diabetes mellitus	0.000352	0.00295	CcSEcCtD
Orphenadrine—Palpitations—Orlistat—type 2 diabetes mellitus	0.000349	0.00292	CcSEcCtD
Orphenadrine—Nausea—Rosiglitazone—type 2 diabetes mellitus	0.000349	0.00292	CcSEcCtD
Orphenadrine—Tachycardia—Gliclazide—type 2 diabetes mellitus	0.000347	0.0029	CcSEcCtD
Orphenadrine—Skin disorder—Gliclazide—type 2 diabetes mellitus	0.000345	0.00289	CcSEcCtD
Orphenadrine—Asthenia—Glimepiride—type 2 diabetes mellitus	0.000344	0.00288	CcSEcCtD
Orphenadrine—Urticaria—Bromocriptine—type 2 diabetes mellitus	0.000344	0.00288	CcSEcCtD
Orphenadrine—Vision blurred—Metformin—type 2 diabetes mellitus	0.000343	0.00287	CcSEcCtD
Orphenadrine—Asthenia—Sitagliptin—type 2 diabetes mellitus	0.000343	0.00287	CcSEcCtD
Orphenadrine—Tremor—Metformin—type 2 diabetes mellitus	0.000341	0.00286	CcSEcCtD
Orphenadrine—Dizziness—Glipizide—type 2 diabetes mellitus	0.00034	0.00285	CcSEcCtD
Orphenadrine—Pruritus—Glimepiride—type 2 diabetes mellitus	0.000339	0.00284	CcSEcCtD
Orphenadrine—Tension—Irbesartan—type 2 diabetes mellitus	0.000337	0.00282	CcSEcCtD
Orphenadrine—Vomiting—Glipizide—type 2 diabetes mellitus	0.000327	0.00274	CcSEcCtD
Orphenadrine—Anaphylactic shock—Valsartan—type 2 diabetes mellitus	0.000326	0.00273	CcSEcCtD
Orphenadrine—Feeling abnormal—Glyburide—type 2 diabetes mellitus	0.000326	0.00273	CcSEcCtD
Orphenadrine—Dizziness—Pioglitazone—type 2 diabetes mellitus	0.000326	0.00273	CcSEcCtD
Orphenadrine—Vision blurred—Irbesartan—type 2 diabetes mellitus	0.000324	0.00271	CcSEcCtD
Orphenadrine—Anaphylactic shock—Orlistat—type 2 diabetes mellitus	0.000322	0.0027	CcSEcCtD
Orphenadrine—Headache—Glipizide—type 2 diabetes mellitus	0.000322	0.0027	CcSEcCtD
Orphenadrine—Tremor—Irbesartan—type 2 diabetes mellitus	0.000322	0.0027	CcSEcCtD
Orphenadrine—Palpitations—Metformin—type 2 diabetes mellitus	0.000322	0.00269	CcSEcCtD
Orphenadrine—Tension—Losartan—type 2 diabetes mellitus	0.000317	0.00266	CcSEcCtD
Orphenadrine—Dizziness—Glimepiride—type 2 diabetes mellitus	0.000317	0.00266	CcSEcCtD
Orphenadrine—Skin disorder—Valsartan—type 2 diabetes mellitus	0.000317	0.00265	CcSEcCtD
Orphenadrine—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.000316	0.00265	CcSEcCtD
Orphenadrine—Agitation—Irbesartan—type 2 diabetes mellitus	0.000316	0.00264	CcSEcCtD
Orphenadrine—Somnolence—Gliclazide—type 2 diabetes mellitus	0.000316	0.00264	CcSEcCtD
Orphenadrine—Urticaria—Glyburide—type 2 diabetes mellitus	0.000314	0.00263	CcSEcCtD
Orphenadrine—Skin disorder—Orlistat—type 2 diabetes mellitus	0.000313	0.00262	CcSEcCtD
Orphenadrine—Asthenia—Bromocriptine—type 2 diabetes mellitus	0.00031	0.0026	CcSEcCtD
Orphenadrine—Headache—Pioglitazone—type 2 diabetes mellitus	0.000308	0.00258	CcSEcCtD
Orphenadrine—Nausea—Glipizide—type 2 diabetes mellitus	0.000305	0.00256	CcSEcCtD
Orphenadrine—Vomiting—Glimepiride—type 2 diabetes mellitus	0.000305	0.00255	CcSEcCtD
Orphenadrine—Vision blurred—Losartan—type 2 diabetes mellitus	0.000305	0.00255	CcSEcCtD
Orphenadrine—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.000304	0.00255	CcSEcCtD
Orphenadrine—Constipation—Gliclazide—type 2 diabetes mellitus	0.000304	0.00254	CcSEcCtD
Orphenadrine—Tremor—Losartan—type 2 diabetes mellitus	0.000303	0.00254	CcSEcCtD
Orphenadrine—Headache—Glimepiride—type 2 diabetes mellitus	0.0003	0.00252	CcSEcCtD
Orphenadrine—Headache—Sitagliptin—type 2 diabetes mellitus	0.000299	0.00251	CcSEcCtD
Orphenadrine—Agitation—Losartan—type 2 diabetes mellitus	0.000297	0.00249	CcSEcCtD
Orphenadrine—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	0.000293	0.00245	CcSEcCtD
Orphenadrine—Hypersensitivity—Glyburide—type 2 diabetes mellitus	0.000291	0.00244	CcSEcCtD
Orphenadrine—Somnolence—Valsartan—type 2 diabetes mellitus	0.00029	0.00243	CcSEcCtD
Orphenadrine—Skin disorder—Metformin—type 2 diabetes mellitus	0.000289	0.00242	CcSEcCtD
Orphenadrine—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.000286	0.0024	CcSEcCtD
Orphenadrine—Palpitations—Losartan—type 2 diabetes mellitus	0.000286	0.00239	CcSEcCtD
Orphenadrine—Nausea—Glimepiride—type 2 diabetes mellitus	0.000285	0.00239	CcSEcCtD
Orphenadrine—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000284	0.00238	CcSEcCtD
Orphenadrine—Asthenia—Glyburide—type 2 diabetes mellitus	0.000284	0.00238	CcSEcCtD
Orphenadrine—Urticaria—Gliclazide—type 2 diabetes mellitus	0.000282	0.00236	CcSEcCtD
Orphenadrine—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	0.00028	0.00235	CcSEcCtD
Orphenadrine—Pruritus—Glyburide—type 2 diabetes mellitus	0.00028	0.00234	CcSEcCtD
Orphenadrine—Constipation—Valsartan—type 2 diabetes mellitus	0.000279	0.00234	CcSEcCtD
Orphenadrine—KCNH2—cardiovascular system—type 2 diabetes mellitus	0.000276	0.0188	CbGeAlD
Orphenadrine—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.000275	0.0023	CcSEcCtD
Orphenadrine—Tachycardia—Irbesartan—type 2 diabetes mellitus	0.000274	0.00229	CcSEcCtD
Orphenadrine—Skin disorder—Irbesartan—type 2 diabetes mellitus	0.000272	0.00228	CcSEcCtD
Orphenadrine—Tension—Ramipril—type 2 diabetes mellitus	0.000272	0.00228	CcSEcCtD
Orphenadrine—Headache—Bromocriptine—type 2 diabetes mellitus	0.000271	0.00227	CcSEcCtD
Orphenadrine—Confusional state—Losartan—type 2 diabetes mellitus	0.000266	0.00223	CcSEcCtD
Orphenadrine—Feeling abnormal—Orlistat—type 2 diabetes mellitus	0.000266	0.00222	CcSEcCtD
Orphenadrine—Somnolence—Metformin—type 2 diabetes mellitus	0.000264	0.00221	CcSEcCtD
Orphenadrine—Anaphylactic shock—Losartan—type 2 diabetes mellitus	0.000264	0.00221	CcSEcCtD
Orphenadrine—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	0.000262	0.00219	CcSEcCtD
Orphenadrine—Tremor—Ramipril—type 2 diabetes mellitus	0.00026	0.00218	CcSEcCtD
Orphenadrine—Urticaria—Valsartan—type 2 diabetes mellitus	0.000259	0.00217	CcSEcCtD
Orphenadrine—Tachycardia—Losartan—type 2 diabetes mellitus	0.000258	0.00216	CcSEcCtD
Orphenadrine—Nausea—Bromocriptine—type 2 diabetes mellitus	0.000257	0.00215	CcSEcCtD
Orphenadrine—Urticaria—Orlistat—type 2 diabetes mellitus	0.000256	0.00214	CcSEcCtD
Orphenadrine—Asthenia—Gliclazide—type 2 diabetes mellitus	0.000255	0.00213	CcSEcCtD
Orphenadrine—Agitation—Ramipril—type 2 diabetes mellitus	0.000255	0.00213	CcSEcCtD
Orphenadrine—Constipation—Metformin—type 2 diabetes mellitus	0.000254	0.00213	CcSEcCtD
Orphenadrine—CYP2B6—nephron tubule—type 2 diabetes mellitus	0.000252	0.0172	CbGeAlD
Orphenadrine—Vomiting—Glyburide—type 2 diabetes mellitus	0.000251	0.00211	CcSEcCtD
Orphenadrine—Pruritus—Gliclazide—type 2 diabetes mellitus	0.000251	0.0021	CcSEcCtD
Orphenadrine—Somnolence—Irbesartan—type 2 diabetes mellitus	0.000249	0.00209	CcSEcCtD
Orphenadrine—Headache—Glyburide—type 2 diabetes mellitus	0.000248	0.00207	CcSEcCtD
Orphenadrine—Palpitations—Ramipril—type 2 diabetes mellitus	0.000245	0.00205	CcSEcCtD
Orphenadrine—Feeling abnormal—Metformin—type 2 diabetes mellitus	0.000245	0.00205	CcSEcCtD
Orphenadrine—Hypersensitivity—Valsartan—type 2 diabetes mellitus	0.00024	0.00201	CcSEcCtD
Orphenadrine—Constipation—Irbesartan—type 2 diabetes mellitus	0.00024	0.00201	CcSEcCtD
Orphenadrine—Hypersensitivity—Orlistat—type 2 diabetes mellitus	0.000238	0.00199	CcSEcCtD
Orphenadrine—CYP2E1—nephron tubule—type 2 diabetes mellitus	0.000236	0.0161	CbGeAlD
Orphenadrine—Urticaria—Metformin—type 2 diabetes mellitus	0.000236	0.00198	CcSEcCtD
Orphenadrine—Nausea—Glyburide—type 2 diabetes mellitus	0.000235	0.00197	CcSEcCtD
Orphenadrine—Dizziness—Gliclazide—type 2 diabetes mellitus	0.000235	0.00197	CcSEcCtD
Orphenadrine—Somnolence—Losartan—type 2 diabetes mellitus	0.000235	0.00196	CcSEcCtD
Orphenadrine—Asthenia—Valsartan—type 2 diabetes mellitus	0.000234	0.00196	CcSEcCtD
Orphenadrine—Asthenia—Orlistat—type 2 diabetes mellitus	0.000231	0.00194	CcSEcCtD
Orphenadrine—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	0.000231	0.00193	CcSEcCtD
Orphenadrine—Pruritus—Valsartan—type 2 diabetes mellitus	0.000231	0.00193	CcSEcCtD
Orphenadrine—Confusional state—Ramipril—type 2 diabetes mellitus	0.000228	0.00191	CcSEcCtD
Orphenadrine—Pruritus—Orlistat—type 2 diabetes mellitus	0.000228	0.00191	CcSEcCtD
Orphenadrine—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	0.000226	0.00189	CcSEcCtD
Orphenadrine—CYP2B6—cardiovascular system—type 2 diabetes mellitus	0.000226	0.0154	CbGeAlD
Orphenadrine—Vomiting—Gliclazide—type 2 diabetes mellitus	0.000226	0.00189	CcSEcCtD
Orphenadrine—Constipation—Losartan—type 2 diabetes mellitus	0.000226	0.00189	CcSEcCtD
Orphenadrine—Urticaria—Irbesartan—type 2 diabetes mellitus	0.000223	0.00187	CcSEcCtD
Orphenadrine—Headache—Gliclazide—type 2 diabetes mellitus	0.000222	0.00186	CcSEcCtD
Orphenadrine—CYP2B6—kidney—type 2 diabetes mellitus	0.000221	0.0151	CbGeAlD
Orphenadrine—Tachycardia—Ramipril—type 2 diabetes mellitus	0.000221	0.00185	CcSEcCtD
Orphenadrine—Skin disorder—Ramipril—type 2 diabetes mellitus	0.00022	0.00184	CcSEcCtD
Orphenadrine—Feeling abnormal—Losartan—type 2 diabetes mellitus	0.000217	0.00182	CcSEcCtD
Orphenadrine—Dizziness—Valsartan—type 2 diabetes mellitus	0.000216	0.00181	CcSEcCtD
Orphenadrine—Dizziness—Orlistat—type 2 diabetes mellitus	0.000213	0.00179	CcSEcCtD
Orphenadrine—Asthenia—Metformin—type 2 diabetes mellitus	0.000213	0.00179	CcSEcCtD
Orphenadrine—CYP2E1—cardiovascular system—type 2 diabetes mellitus	0.000212	0.0145	CbGeAlD
Orphenadrine—Nausea—Gliclazide—type 2 diabetes mellitus	0.000211	0.00177	CcSEcCtD
Orphenadrine—Pruritus—Metformin—type 2 diabetes mellitus	0.00021	0.00176	CcSEcCtD
Orphenadrine—Urticaria—Losartan—type 2 diabetes mellitus	0.00021	0.00176	CcSEcCtD
Orphenadrine—CYP2E1—kidney—type 2 diabetes mellitus	0.000208	0.0142	CbGeAlD
Orphenadrine—Vomiting—Valsartan—type 2 diabetes mellitus	0.000207	0.00174	CcSEcCtD
Orphenadrine—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	0.000207	0.00173	CcSEcCtD
Orphenadrine—Vomiting—Orlistat—type 2 diabetes mellitus	0.000205	0.00172	CcSEcCtD
Orphenadrine—Headache—Valsartan—type 2 diabetes mellitus	0.000204	0.00171	CcSEcCtD
Orphenadrine—CYP2E1—cortex of kidney—type 2 diabetes mellitus	0.000202	0.0138	CbGeAlD
Orphenadrine—Headache—Orlistat—type 2 diabetes mellitus	0.000202	0.00169	CcSEcCtD
Orphenadrine—Asthenia—Irbesartan—type 2 diabetes mellitus	0.000201	0.00168	CcSEcCtD
Orphenadrine—Somnolence—Ramipril—type 2 diabetes mellitus	0.000201	0.00168	CcSEcCtD
Orphenadrine—Pruritus—Irbesartan—type 2 diabetes mellitus	0.000198	0.00166	CcSEcCtD
Orphenadrine—Dizziness—Metformin—type 2 diabetes mellitus	0.000196	0.00165	CcSEcCtD
Orphenadrine—Captodiame—HTR2C—type 2 diabetes mellitus	0.000196	0.0433	CrCbGaD
Orphenadrine—HRH1—adipose tissue—type 2 diabetes mellitus	0.000195	0.0133	CbGeAlD
Orphenadrine—Hypersensitivity—Losartan—type 2 diabetes mellitus	0.000194	0.00163	CcSEcCtD
Orphenadrine—Nausea—Valsartan—type 2 diabetes mellitus	0.000194	0.00162	CcSEcCtD
Orphenadrine—Constipation—Ramipril—type 2 diabetes mellitus	0.000193	0.00162	CcSEcCtD
Orphenadrine—Nausea—Orlistat—type 2 diabetes mellitus	0.000191	0.0016	CcSEcCtD
Orphenadrine—Asthenia—Losartan—type 2 diabetes mellitus	0.000189	0.00159	CcSEcCtD
Orphenadrine—Vomiting—Metformin—type 2 diabetes mellitus	0.000189	0.00158	CcSEcCtD
Orphenadrine—Pruritus—Losartan—type 2 diabetes mellitus	0.000187	0.00156	CcSEcCtD
Orphenadrine—Feeling abnormal—Ramipril—type 2 diabetes mellitus	0.000186	0.00156	CcSEcCtD
Orphenadrine—Headache—Metformin—type 2 diabetes mellitus	0.000186	0.00156	CcSEcCtD
Orphenadrine—Dizziness—Irbesartan—type 2 diabetes mellitus	0.000185	0.00155	CcSEcCtD
Orphenadrine—Reboxetine—HTR2C—type 2 diabetes mellitus	0.000184	0.0407	CrCbGaD
Orphenadrine—Urticaria—Ramipril—type 2 diabetes mellitus	0.00018	0.00151	CcSEcCtD
Orphenadrine—Bedaquiline—CYP3A4—type 2 diabetes mellitus	0.000179	0.0395	CrCbGaD
Orphenadrine—Vomiting—Irbesartan—type 2 diabetes mellitus	0.000178	0.00149	CcSEcCtD
Orphenadrine—Nausea—Metformin—type 2 diabetes mellitus	0.000176	0.00148	CcSEcCtD
Orphenadrine—Headache—Irbesartan—type 2 diabetes mellitus	0.000176	0.00147	CcSEcCtD
Orphenadrine—Dizziness—Losartan—type 2 diabetes mellitus	0.000174	0.00146	CcSEcCtD
Orphenadrine—Phenoxybenzamine—CALM1—type 2 diabetes mellitus	0.000172	0.0379	CrCbGaD
Orphenadrine—Vomiting—Losartan—type 2 diabetes mellitus	0.000168	0.00141	CcSEcCtD
Orphenadrine—CYP3A4—kidney—type 2 diabetes mellitus	0.000167	0.0114	CbGeAlD
Orphenadrine—Hypersensitivity—Ramipril—type 2 diabetes mellitus	0.000167	0.0014	CcSEcCtD
Orphenadrine—Nausea—Irbesartan—type 2 diabetes mellitus	0.000167	0.00139	CcSEcCtD
Orphenadrine—Headache—Losartan—type 2 diabetes mellitus	0.000165	0.00138	CcSEcCtD
Orphenadrine—Asthenia—Ramipril—type 2 diabetes mellitus	0.000162	0.00136	CcSEcCtD
Orphenadrine—Pruritus—Ramipril—type 2 diabetes mellitus	0.00016	0.00134	CcSEcCtD
Orphenadrine—Nausea—Losartan—type 2 diabetes mellitus	0.000157	0.00131	CcSEcCtD
Orphenadrine—Dizziness—Ramipril—type 2 diabetes mellitus	0.00015	0.00125	CcSEcCtD
Orphenadrine—Vomiting—Ramipril—type 2 diabetes mellitus	0.000144	0.0012	CcSEcCtD
Orphenadrine—Headache—Ramipril—type 2 diabetes mellitus	0.000142	0.00119	CcSEcCtD
Orphenadrine—Promethazine—CALM1—type 2 diabetes mellitus	0.000141	0.0312	CrCbGaD
Orphenadrine—CYP2B6—liver—type 2 diabetes mellitus	0.00014	0.00954	CbGeAlD
Orphenadrine—Nausea—Ramipril—type 2 diabetes mellitus	0.000134	0.00113	CcSEcCtD
Orphenadrine—CYP2E1—liver—type 2 diabetes mellitus	0.000131	0.00895	CbGeAlD
Orphenadrine—Fluoxetine—HTR2C—type 2 diabetes mellitus	0.000116	0.0255	CrCbGaD
Orphenadrine—Toremifene—CYP1A2—type 2 diabetes mellitus	0.00011	0.0244	CrCbGaD
Orphenadrine—CYP3A4—liver—type 2 diabetes mellitus	0.000106	0.0072	CbGeAlD
Orphenadrine—Cyclobenzaprine—CYP1A2—type 2 diabetes mellitus	9.53e-05	0.0211	CrCbGaD
Orphenadrine—Reboxetine—CYP3A4—type 2 diabetes mellitus	9.2e-05	0.0203	CrCbGaD
Orphenadrine—Fluoxetine—CYP1A2—type 2 diabetes mellitus	8.72e-05	0.0193	CrCbGaD
Orphenadrine—Carbinoxamine—CYP2E1—type 2 diabetes mellitus	8.24e-05	0.0182	CrCbGaD
Orphenadrine—Benzphetamine—ADRA2A—type 2 diabetes mellitus	8.13e-05	0.018	CrCbGaD
Orphenadrine—Warfarin—CYP1A2—type 2 diabetes mellitus	7.95e-05	0.0176	CrCbGaD
Orphenadrine—Phenoxybenzamine—ADRA2A—type 2 diabetes mellitus	7.77e-05	0.0172	CrCbGaD
Orphenadrine—Atomoxetine—HTR2C—type 2 diabetes mellitus	7.42e-05	0.0164	CrCbGaD
Orphenadrine—Toremifene—CYP3A4—type 2 diabetes mellitus	7.3e-05	0.0161	CrCbGaD
Orphenadrine—Brompheniramine—CYP2E1—type 2 diabetes mellitus	7.14e-05	0.0158	CrCbGaD
Orphenadrine—Alimemazine—CYP3A4—type 2 diabetes mellitus	6.85e-05	0.0151	CrCbGaD
Orphenadrine—Fenoprofen—PTGS2—type 2 diabetes mellitus	6.73e-05	0.0149	CrCbGaD
Orphenadrine—Trimipramine—ADRA2A—type 2 diabetes mellitus	6.63e-05	0.0147	CrCbGaD
Orphenadrine—Tamoxifen—ABCC2—type 2 diabetes mellitus	6.6e-05	0.0146	CrCbGaD
Orphenadrine—Modafinil—CYP1A2—type 2 diabetes mellitus	6.51e-05	0.0144	CrCbGaD
Orphenadrine—Doxepin—ADRA2A—type 2 diabetes mellitus	6.32e-05	0.014	CrCbGaD
Orphenadrine—Cyclobenzaprine—CYP3A4—type 2 diabetes mellitus	6.31e-05	0.0139	CrCbGaD
Orphenadrine—Trimipramine—HTR2C—type 2 diabetes mellitus	6.1e-05	0.0135	CrCbGaD
Orphenadrine—Tolterodine—CYP3A4—type 2 diabetes mellitus	6.05e-05	0.0134	CrCbGaD
Orphenadrine—Fenoprofen—ALB—type 2 diabetes mellitus	6e-05	0.0133	CrCbGaD
Orphenadrine—Phenprocoumon—CYP3A4—type 2 diabetes mellitus	5.93e-05	0.0131	CrCbGaD
Orphenadrine—Doxepin—HTR2C—type 2 diabetes mellitus	5.82e-05	0.0129	CrCbGaD
Orphenadrine—Fluoxetine—CYP3A4—type 2 diabetes mellitus	5.77e-05	0.0127	CrCbGaD
Orphenadrine—Promazine—ADRA2A—type 2 diabetes mellitus	5.62e-05	0.0124	CrCbGaD
Orphenadrine—Warfarin—CYP3A4—type 2 diabetes mellitus	5.26e-05	0.0116	CrCbGaD
Orphenadrine—Carbinoxamine—CYP3A4—type 2 diabetes mellitus	5.19e-05	0.0115	CrCbGaD
Orphenadrine—Phenprocoumon—ALB—type 2 diabetes mellitus	5.17e-05	0.0114	CrCbGaD
Orphenadrine—Promazine—HTR2C—type 2 diabetes mellitus	5.17e-05	0.0114	CrCbGaD
Orphenadrine—Fluoxetine—ALB—type 2 diabetes mellitus	5.03e-05	0.0111	CrCbGaD
Orphenadrine—Levomethadyl Acetate—CYP3A4—type 2 diabetes mellitus	4.93e-05	0.0109	CrCbGaD
Orphenadrine—Amitriptyline—ADRA2A—type 2 diabetes mellitus	4.89e-05	0.0108	CrCbGaD
Orphenadrine—Tamoxifen—CYP2E1—type 2 diabetes mellitus	4.63e-05	0.0102	CrCbGaD
Orphenadrine—Warfarin—ALB—type 2 diabetes mellitus	4.59e-05	0.0101	CrCbGaD
Orphenadrine—Imipramine—HTR2C—type 2 diabetes mellitus	4.53e-05	0.01	CrCbGaD
Orphenadrine—Diphenhydramine—CYP1A2—type 2 diabetes mellitus	4.52e-05	0.00999	CrCbGaD
Orphenadrine—Amitriptyline—HTR2C—type 2 diabetes mellitus	4.5e-05	0.00994	CrCbGaD
Orphenadrine—Brompheniramine—CYP3A4—type 2 diabetes mellitus	4.5e-05	0.00993	CrCbGaD
Orphenadrine—Chlorphenamine—CYP3A4—type 2 diabetes mellitus	4.41e-05	0.00975	CrCbGaD
Orphenadrine—Tamoxifen—CYP1A2—type 2 diabetes mellitus	4.4e-05	0.00973	CrCbGaD
Orphenadrine—Doxepin—CYP1A2—type 2 diabetes mellitus	4.39e-05	0.0097	CrCbGaD
Orphenadrine—Methadone—CYP1A2—type 2 diabetes mellitus	4.37e-05	0.00965	CrCbGaD
Orphenadrine—Modafinil—CYP3A4—type 2 diabetes mellitus	4.31e-05	0.00952	CrCbGaD
Orphenadrine—Dextropropoxyphene—CYP3A4—type 2 diabetes mellitus	4.26e-05	0.00942	CrCbGaD
Orphenadrine—Promazine—CYP1A2—type 2 diabetes mellitus	3.9e-05	0.00862	CrCbGaD
Orphenadrine—Benzphetamine—CYP3A4—type 2 diabetes mellitus	3.74e-05	0.00826	CrCbGaD
Orphenadrine—Atomoxetine—CYP3A4—type 2 diabetes mellitus	3.71e-05	0.00819	CrCbGaD
Orphenadrine—Imipramine—CYP2E1—type 2 diabetes mellitus	3.59e-05	0.00793	CrCbGaD
Orphenadrine—Phenoxybenzamine—CYP3A4—type 2 diabetes mellitus	3.57e-05	0.00789	CrCbGaD
Orphenadrine—Amitriptyline—CYP2E1—type 2 diabetes mellitus	3.57e-05	0.00788	CrCbGaD
Orphenadrine—Imipramine—CYP1A2—type 2 diabetes mellitus	3.42e-05	0.00755	CrCbGaD
Orphenadrine—Amitriptyline—CYP1A2—type 2 diabetes mellitus	3.39e-05	0.0075	CrCbGaD
Orphenadrine—Trimipramine—CYP3A4—type 2 diabetes mellitus	3.05e-05	0.00674	CrCbGaD
Orphenadrine—Tamoxifen—CYP3A4—type 2 diabetes mellitus	2.92e-05	0.00644	CrCbGaD
Orphenadrine—Doxepin—CYP3A4—type 2 diabetes mellitus	2.91e-05	0.00642	CrCbGaD
Orphenadrine—Methadone—CYP3A4—type 2 diabetes mellitus	2.89e-05	0.00639	CrCbGaD
Orphenadrine—Promazine—CYP3A4—type 2 diabetes mellitus	2.58e-05	0.00571	CrCbGaD
Orphenadrine—Imipramine—CYP3A4—type 2 diabetes mellitus	2.26e-05	0.005	CrCbGaD
Orphenadrine—Amitriptyline—CYP3A4—type 2 diabetes mellitus	2.25e-05	0.00497	CrCbGaD
Orphenadrine—Amitriptyline—ALB—type 2 diabetes mellitus	1.96e-05	0.00433	CrCbGaD
Orphenadrine—HRH1—Signaling by GPCR—CALM1—type 2 diabetes mellitus	6.15e-06	6.6e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—CYBA—type 2 diabetes mellitus	6.15e-06	6.6e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—EDNRA—type 2 diabetes mellitus	6.08e-06	6.52e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—CALM1—type 2 diabetes mellitus	6.05e-06	6.49e-05	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—ADRA2A—type 2 diabetes mellitus	6.05e-06	6.49e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—CYBA—type 2 diabetes mellitus	6.05e-06	6.49e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—ADRA2A—type 2 diabetes mellitus	6.05e-06	6.49e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—GHRL—type 2 diabetes mellitus	6.02e-06	6.46e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—PLAT—type 2 diabetes mellitus	6.02e-06	6.46e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—ADRA2A—type 2 diabetes mellitus	5.95e-06	6.38e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—CALCA—type 2 diabetes mellitus	5.95e-06	6.38e-05	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—CYP2E1—type 2 diabetes mellitus	5.94e-06	6.37e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—PLAT—type 2 diabetes mellitus	5.92e-06	6.35e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—GHRL—type 2 diabetes mellitus	5.92e-06	6.35e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—OXCT1—type 2 diabetes mellitus	5.88e-06	6.3e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—CYTB—type 2 diabetes mellitus	5.88e-06	6.3e-05	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—CYP1A2—type 2 diabetes mellitus	5.87e-06	6.3e-05	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—SLC2A1—type 2 diabetes mellitus	5.87e-06	6.3e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—CALCA—type 2 diabetes mellitus	5.85e-06	6.28e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—PRKCB—type 2 diabetes mellitus	5.78e-06	6.2e-05	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—CYP1A2—type 2 diabetes mellitus	5.75e-06	6.17e-05	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—SLC2A1—type 2 diabetes mellitus	5.75e-06	6.17e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—SRD5A1—type 2 diabetes mellitus	5.73e-06	6.14e-05	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—CYP3A4—type 2 diabetes mellitus	5.73e-06	6.14e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—PRKCB—type 2 diabetes mellitus	5.69e-06	6.1e-05	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—SLC2A4—type 2 diabetes mellitus	5.63e-06	6.04e-05	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—GCG—type 2 diabetes mellitus	5.63e-06	6.04e-05	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—CYP3A4—type 2 diabetes mellitus	5.61e-06	6.02e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	5.6e-06	6.01e-05	CbGpPWpGaD
Orphenadrine—HRH1—GPCR downstream signaling—AKT2—type 2 diabetes mellitus	5.57e-06	5.98e-05	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—SLC2A4—type 2 diabetes mellitus	5.51e-06	5.91e-05	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—GCG—type 2 diabetes mellitus	5.51e-06	5.91e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	5.51e-06	5.91e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—GCG—type 2 diabetes mellitus	5.51e-06	5.91e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—PTPN1—type 2 diabetes mellitus	5.51e-06	5.91e-05	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR downstream signaling—AKT2—type 2 diabetes mellitus	5.49e-06	5.88e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—HSD17B3—type 2 diabetes mellitus	5.46e-06	5.86e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—ACACA—type 2 diabetes mellitus	5.46e-06	5.86e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—STAR—type 2 diabetes mellitus	5.46e-06	5.86e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—GCG—type 2 diabetes mellitus	5.42e-06	5.81e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—PTPN1—type 2 diabetes mellitus	5.42e-06	5.81e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	5.42e-06	5.81e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	5.4e-06	5.79e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	5.33e-06	5.72e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	5.31e-06	5.7e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—ABCC8—type 2 diabetes mellitus	5.24e-06	5.62e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—CBS—type 2 diabetes mellitus	5.24e-06	5.62e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—CCL2—type 2 diabetes mellitus	5.15e-06	5.53e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—CCL2—type 2 diabetes mellitus	5.07e-06	5.44e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—AKT2—type 2 diabetes mellitus	5.06e-06	5.43e-05	CbGpPWpGaD
Orphenadrine—HRH1—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	5.06e-06	5.43e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—COX2—type 2 diabetes mellitus	5.04e-06	5.41e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—SLC5A2—type 2 diabetes mellitus	5.04e-06	5.41e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—AKT2—type 2 diabetes mellitus	4.98e-06	5.34e-05	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	4.98e-06	5.34e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—NCOA6—type 2 diabetes mellitus	4.95e-06	5.31e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—HSD11B1—type 2 diabetes mellitus	4.87e-06	5.22e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—UCP3—type 2 diabetes mellitus	4.87e-06	5.22e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—UCP2—type 2 diabetes mellitus	4.87e-06	5.22e-05	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—GNB3—type 2 diabetes mellitus	4.85e-06	5.2e-05	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—PPARGC1A—type 2 diabetes mellitus	4.85e-06	5.2e-05	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—HMOX1—type 2 diabetes mellitus	4.83e-06	5.18e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	4.79e-06	5.14e-05	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—CAT—type 2 diabetes mellitus	4.76e-06	5.11e-05	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—GNB3—type 2 diabetes mellitus	4.75e-06	5.1e-05	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—PPARGC1A—type 2 diabetes mellitus	4.75e-06	5.1e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—GNB3—type 2 diabetes mellitus	4.75e-06	5.09e-05	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—HMOX1—type 2 diabetes mellitus	4.73e-06	5.07e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	4.71e-06	5.06e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—AVP—type 2 diabetes mellitus	4.68e-06	5.02e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—MMP3—type 2 diabetes mellitus	4.68e-06	5.02e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—GNB3—type 2 diabetes mellitus	4.67e-06	5.01e-05	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—CAT—type 2 diabetes mellitus	4.67e-06	5.01e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—IGF2—type 2 diabetes mellitus	4.66e-06	5e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	4.64e-06	4.98e-05	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—APOB—type 2 diabetes mellitus	4.63e-06	4.96e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—AVP—type 2 diabetes mellitus	4.61e-06	4.94e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—MMP3—type 2 diabetes mellitus	4.61e-06	4.94e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	4.59e-06	4.93e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—IGF2—type 2 diabetes mellitus	4.59e-06	4.92e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—PCK1—type 2 diabetes mellitus	4.58e-06	4.91e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	4.57e-06	4.9e-05	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—APOB—type 2 diabetes mellitus	4.53e-06	4.86e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—APOB—type 2 diabetes mellitus	4.52e-06	4.85e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	4.52e-06	4.85e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—IGF1R—type 2 diabetes mellitus	4.51e-06	4.83e-05	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—GSTM1—type 2 diabetes mellitus	4.5e-06	4.83e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—EDN1—type 2 diabetes mellitus	4.45e-06	4.78e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—APOB—type 2 diabetes mellitus	4.45e-06	4.78e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—IGF1R—type 2 diabetes mellitus	4.43e-06	4.76e-05	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—LPL—type 2 diabetes mellitus	4.42e-06	4.74e-05	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—GSTM1—type 2 diabetes mellitus	4.41e-06	4.73e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—EDN1—type 2 diabetes mellitus	4.38e-06	4.7e-05	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—LPL—type 2 diabetes mellitus	4.33e-06	4.64e-05	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—ADCY5—type 2 diabetes mellitus	4.32e-06	4.64e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—LPL—type 2 diabetes mellitus	4.32e-06	4.64e-05	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—GPX1—type 2 diabetes mellitus	4.31e-06	4.62e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—HK1—type 2 diabetes mellitus	4.29e-06	4.6e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—LPL—type 2 diabetes mellitus	4.25e-06	4.56e-05	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—ADCY5—type 2 diabetes mellitus	4.24e-06	4.54e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—ADCY5—type 2 diabetes mellitus	4.23e-06	4.54e-05	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—GPX1—type 2 diabetes mellitus	4.22e-06	4.53e-05	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—CD36—type 2 diabetes mellitus	4.2e-06	4.5e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—ADCY5—type 2 diabetes mellitus	4.16e-06	4.46e-05	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—PPP2CA—type 2 diabetes mellitus	4.14e-06	4.45e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—KCNJ11—type 2 diabetes mellitus	4.14e-06	4.44e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—LPA—type 2 diabetes mellitus	4.14e-06	4.44e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—GCKR—type 2 diabetes mellitus	4.14e-06	4.44e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—HSD3B2—type 2 diabetes mellitus	4.14e-06	4.44e-05	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—CD36—type 2 diabetes mellitus	4.11e-06	4.41e-05	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—PPP2CA—type 2 diabetes mellitus	4.06e-06	4.35e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	4.05e-06	4.35e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	3.99e-06	4.28e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—CCR5—type 2 diabetes mellitus	3.98e-06	4.27e-05	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—MTHFR—type 2 diabetes mellitus	3.98e-06	4.27e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—ALDOB—type 2 diabetes mellitus	3.97e-06	4.26e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—CCR5—type 2 diabetes mellitus	3.92e-06	4.2e-05	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—PPARA—type 2 diabetes mellitus	3.9e-06	4.19e-05	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—MTHFR—type 2 diabetes mellitus	3.9e-06	4.18e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—C3—type 2 diabetes mellitus	3.89e-06	4.17e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—C3—type 2 diabetes mellitus	3.83e-06	4.11e-05	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—PPARA—type 2 diabetes mellitus	3.82e-06	4.1e-05	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—AGT—type 2 diabetes mellitus	3.78e-06	4.05e-05	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—CALM1—type 2 diabetes mellitus	3.72e-06	3.99e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—HIF1A—type 2 diabetes mellitus	3.71e-06	3.98e-05	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—APOE—type 2 diabetes mellitus	3.7e-06	3.97e-05	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—AGT—type 2 diabetes mellitus	3.7e-06	3.97e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—IRS2—type 2 diabetes mellitus	3.7e-06	3.97e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—AGT—type 2 diabetes mellitus	3.7e-06	3.97e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—GLP1R—type 2 diabetes mellitus	3.69e-06	3.96e-05	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—APOA1—type 2 diabetes mellitus	3.66e-06	3.93e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—HIF1A—type 2 diabetes mellitus	3.65e-06	3.92e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—IRS2—type 2 diabetes mellitus	3.64e-06	3.91e-05	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—CALM1—type 2 diabetes mellitus	3.64e-06	3.9e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—AGT—type 2 diabetes mellitus	3.64e-06	3.9e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—CALM1—type 2 diabetes mellitus	3.63e-06	3.9e-05	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—APOE—type 2 diabetes mellitus	3.63e-06	3.89e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—APOE—type 2 diabetes mellitus	3.62e-06	3.89e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—LEP—type 2 diabetes mellitus	3.62e-06	3.89e-05	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—APOA1—type 2 diabetes mellitus	3.58e-06	3.85e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—APOA1—type 2 diabetes mellitus	3.58e-06	3.84e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—CALM1—type 2 diabetes mellitus	3.58e-06	3.84e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—LEP—type 2 diabetes mellitus	3.56e-06	3.82e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—APOE—type 2 diabetes mellitus	3.56e-06	3.82e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—APOA1—type 2 diabetes mellitus	3.52e-06	3.78e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—SLC2A2—type 2 diabetes mellitus	3.45e-06	3.7e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—PRKCB—type 2 diabetes mellitus	3.42e-06	3.66e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—MTR—type 2 diabetes mellitus	3.38e-06	3.62e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—CPT1A—type 2 diabetes mellitus	3.38e-06	3.62e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—PRKCB—type 2 diabetes mellitus	3.36e-06	3.61e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—NAMPT—type 2 diabetes mellitus	3.31e-06	3.55e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—HBA1—type 2 diabetes mellitus	3.29e-06	3.53e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—LIPC—type 2 diabetes mellitus	3.29e-06	3.53e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—GCK—type 2 diabetes mellitus	3.29e-06	3.53e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—CYP11A1—type 2 diabetes mellitus	3.27e-06	3.51e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—IRS1—type 2 diabetes mellitus	3.23e-06	3.47e-05	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—PPARG—type 2 diabetes mellitus	3.22e-06	3.46e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—SLC9A1—type 2 diabetes mellitus	3.21e-06	3.44e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—IRS1—type 2 diabetes mellitus	3.18e-06	3.41e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—CETP—type 2 diabetes mellitus	3.17e-06	3.4e-05	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—INS—type 2 diabetes mellitus	3.16e-06	3.39e-05	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—PPARG—type 2 diabetes mellitus	3.16e-06	3.39e-05	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—INS—type 2 diabetes mellitus	3.1e-06	3.32e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—INS—type 2 diabetes mellitus	3.09e-06	3.32e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—INS—type 2 diabetes mellitus	3.04e-06	3.27e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—CCL2—type 2 diabetes mellitus	3.04e-06	3.27e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—CCL2—type 2 diabetes mellitus	3e-06	3.21e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—IGF1—type 2 diabetes mellitus	2.99e-06	3.21e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—AKT2—type 2 diabetes mellitus	2.99e-06	3.21e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—EGFR—type 2 diabetes mellitus	2.98e-06	3.19e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—PSMD6—type 2 diabetes mellitus	2.95e-06	3.16e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—SREBF1—type 2 diabetes mellitus	2.95e-06	3.16e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—SNAP25—type 2 diabetes mellitus	2.95e-06	3.16e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—IGF1—type 2 diabetes mellitus	2.94e-06	3.16e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—AKT2—type 2 diabetes mellitus	2.94e-06	3.16e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—EGFR—type 2 diabetes mellitus	2.93e-06	3.14e-05	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—ALB—type 2 diabetes mellitus	2.9e-06	3.11e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—CTGF—type 2 diabetes mellitus	2.9e-06	3.11e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—HMGCR—type 2 diabetes mellitus	2.87e-06	3.08e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	2.84e-06	3.05e-05	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—ALB—type 2 diabetes mellitus	2.84e-06	3.05e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—ADRA2A—type 2 diabetes mellitus	2.81e-06	3.01e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	2.8e-06	3e-05	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—PIK3R1—type 2 diabetes mellitus	2.77e-06	2.98e-05	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—NOS3—type 2 diabetes mellitus	2.77e-06	2.98e-05	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—PIK3R1—type 2 diabetes mellitus	2.72e-06	2.91e-05	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—NOS3—type 2 diabetes mellitus	2.72e-06	2.91e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—NOS3—type 2 diabetes mellitus	2.71e-06	2.91e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	2.71e-06	2.91e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—CYP2E1—type 2 diabetes mellitus	2.7e-06	2.89e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—NOS3—type 2 diabetes mellitus	2.67e-06	2.86e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	2.67e-06	2.86e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—CYP1A2—type 2 diabetes mellitus	2.67e-06	2.86e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—SLC2A1—type 2 diabetes mellitus	2.67e-06	2.86e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—GCG—type 2 diabetes mellitus	2.56e-06	2.74e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—SLC2A4—type 2 diabetes mellitus	2.56e-06	2.74e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—RELA—type 2 diabetes mellitus	2.55e-06	2.74e-05	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—PTGS2—type 2 diabetes mellitus	2.54e-06	2.72e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—RELA—type 2 diabetes mellitus	2.51e-06	2.7e-05	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—PTGS2—type 2 diabetes mellitus	2.48e-06	2.67e-05	CbGpPWpGaD
Orphenadrine—HRH1—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	2.32e-06	2.49e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—CASP3—type 2 diabetes mellitus	2.3e-06	2.47e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—IL6—type 2 diabetes mellitus	2.29e-06	2.46e-05	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	2.29e-06	2.45e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—CASP3—type 2 diabetes mellitus	2.27e-06	2.43e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—IL6—type 2 diabetes mellitus	2.25e-06	2.42e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—GNB3—type 2 diabetes mellitus	2.2e-06	2.37e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.2e-06	2.37e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—HMOX1—type 2 diabetes mellitus	2.19e-06	2.35e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—MMP9—type 2 diabetes mellitus	2.18e-06	2.34e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—CAT—type 2 diabetes mellitus	2.17e-06	2.32e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	2.15e-06	2.31e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—MMP9—type 2 diabetes mellitus	2.14e-06	2.3e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—NFKB1—type 2 diabetes mellitus	2.12e-06	2.27e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—AKT1—type 2 diabetes mellitus	2.11e-06	2.26e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—APOB—type 2 diabetes mellitus	2.1e-06	2.26e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—AKT1—type 2 diabetes mellitus	2.08e-06	2.23e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—GSTM1—type 2 diabetes mellitus	2.04e-06	2.19e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—LPL—type 2 diabetes mellitus	2.01e-06	2.15e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—SRC—type 2 diabetes mellitus	2.01e-06	2.15e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—SRC—type 2 diabetes mellitus	1.97e-06	2.12e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—ADCY5—type 2 diabetes mellitus	1.96e-06	2.11e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—GPX1—type 2 diabetes mellitus	1.96e-06	2.1e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.95e-06	2.1e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.92e-06	2.06e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—CD36—type 2 diabetes mellitus	1.91e-06	2.05e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—PPP2CA—type 2 diabetes mellitus	1.88e-06	2.02e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—MTHFR—type 2 diabetes mellitus	1.81e-06	1.94e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.79e-06	1.92e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—PPARA—type 2 diabetes mellitus	1.77e-06	1.9e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.77e-06	1.89e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.76e-06	1.89e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.73e-06	1.86e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—AGT—type 2 diabetes mellitus	1.72e-06	1.84e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—CALM1—type 2 diabetes mellitus	1.69e-06	1.81e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—APOE—type 2 diabetes mellitus	1.68e-06	1.8e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—APOA1—type 2 diabetes mellitus	1.66e-06	1.78e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—PPARG—type 2 diabetes mellitus	1.47e-06	1.57e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—INS—type 2 diabetes mellitus	1.44e-06	1.54e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—IL6—type 2 diabetes mellitus	1.35e-06	1.45e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—IL6—type 2 diabetes mellitus	1.33e-06	1.43e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—ALB—type 2 diabetes mellitus	1.32e-06	1.41e-05	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—AKT1—type 2 diabetes mellitus	1.28e-06	1.37e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—PIK3R1—type 2 diabetes mellitus	1.26e-06	1.35e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—NOS3—type 2 diabetes mellitus	1.26e-06	1.35e-05	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—AKT1—type 2 diabetes mellitus	1.25e-06	1.34e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.25e-06	1.34e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.23e-06	1.32e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—PTGS2—type 2 diabetes mellitus	1.15e-06	1.24e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—AKT1—type 2 diabetes mellitus	5.79e-07	6.22e-06	CbGpPWpGaD
